Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;84:293-299

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Snow, T. R.
Right arrow Articles by Esmon, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Snow, T. R.
Right arrow Articles by Esmon, C. T.

Circulation, Vol 84, 293-299, Copyright © 1991 by American Heart Association


ARTICLES

Protein C activation following coronary artery occlusion in the in situ porcine heart

TR Snow, MT Deal, DT Dickey and CT Esmon
Cardiovascular Biology Program, Oklahoma Medical Research Foundation, Oklahoma City.

BACKGROUND. Activated protein C, the body's natural anticoagulant, may play a role in protecting the heart during and following an occlusion of the left anterior descending coronary artery (LAD) in the porcine heart. METHODS AND RESULTS. Infusion of 1 unit thrombin over 30 seconds into the LAD of juvenile pigs produced a prolongation of the Xa clotting time (153 +/- 14%) in blood drawn from the anterior interventricular vein (AIV). The action of the anticoagulant was blocked by a polyclonal immunoglobulin G antibody directed against porcine activated protein C. A brief (30 seconds) occlusion of the LAD induced a similar prolongation of the Xa clotting time (138 +/- 11%), which was also blocked by the polyclonal antibody. To determine whether activated protein C helps sustain the heart during and following a 2- minute occlusion, three groups of pigs were studied: 11 controls, six receiving activated porcine protein C, and nine receiving a monoclonal antibody (HPC4) that blocks protein C activation. Relative to the controls, HPC4-treated animals recovered function, as measured by the maximum time derivative of left ventricular pressure and segmental shortening, more slowly and were not able to sustain this recovery. Animals receiving activated protein C recovered more quickly and sustained this recovery. CONCLUSIONS. These data indicate that an ischemic insult induces rapid activation of protein C in the coronary microcirulation and that blocking this activation impairs recovery.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
P. Raivio, R. Lassila, and J. Petaja
Thrombin in myocardial ischemia-reperfusion during cardiac surgery.
Ann. Thorac. Surg., July 1, 2009; 88(1): 318 - 325.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Raivio, J. A. Fernandez, A. Kuitunen, J. H. Griffin, R. Lassila, and J. Petaja
Activation of protein C and hemodynamic recovery after coronary artery bypass surgery
J. Thorac. Cardiovasc. Surg., January 1, 2007; 133(1): 44 - 51.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. E. Hafer-Macko, F. M. Ivey, K. A. Gyure, J. D. Sorkin, and R. F. Macko
Thrombomodulin Deficiency in Human Diabetic Nerve Microvasculature
Diabetes, June 1, 2002; 51(6): 1957 - 1963.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Oka, E. C. Gabazza, Y. Taguchi, M. Yamaguchi, S. Nakashima, K. Suzuki, Y. Adachi, and I. Imoto
Role of Activated Protein C in Helicobacter pylori-Associated Gastritis
Infect. Immun., May 1, 2000; 68(5): 2863 - 2869.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Petaja, E. Pesonen, J. A. Fernandez, A. E. Vento, O. J. Ramo, and J. H. Griffin
CARDIOPULMONARY BYPASS AND ACTIVATION OF ANTITHROMBOTIC PLASMA PROTEIN C
J. Thorac. Cardiovasc. Surg., September 1, 1999; 118(3): 422 - 429.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. F. Macko, L. A. Killewich, J. A. Fernandez, D. K. Cox, A. Gruber, and J. H. Griffin
Brain-Specific Protein C Activation During Carotid Artery Occlusion in Humans
Stroke, March 1, 1999; 30(3): 542 - 545.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Wang, N. D. Tran, M. Kittaka, M. J. Fisher, S. S. Schreiber, and B. V. Zlokovic
Thrombomodulin Expression in Bovine Brain Capillaries : Anticoagulant Function of the Blood-Brain Barrier, Regional Differences, and Regulatory Mechanisms
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3139 - 3146.
[Abstract] [Full Text]


Home page
StrokeHome page
N. D. Tran, V. L.Y. Wong, S. S. Schreiber, J. V. Bready, M. Fisher, and K. Peters
Regulation of Brain Capillary Endothelial Thrombomodulin mRNA Expression
Stroke, December 1, 1996; 27(12): 2304 - 2311.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Petaja, U. Lundstrom, H. Sairanen, E. Marttinen, and J. H. Griffin
CENTRAL VENOUS THROMBOSIS AFTER CARDIAC OPERATIONS IN CHILDREN
J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 883 - 889.
[Abstract] [Full Text]


Home page
StrokeHome page
M. Fisher, J. A. Fernandez, S. F. Ameriso, D. Xie, A. Gruber, A. Paganini-Hill, and J. H. Griffin
Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine506->Glutamine Mutation
Stroke, July 1, 1996; 27(7): 1163 - 1166.
[Abstract] [Full Text]